乌干达一家城市HIV诊所实施常规病毒载量监测后对可检测病毒载量患者的管理评价

IF 1.1 Q4 INFECTIOUS DISEASES
AIDS Research and Treatment Pub Date : 2019-12-15 eCollection Date: 2019-01-01 DOI:10.1155/2019/9271450
Nsumba Steven Mark, Musomba Rachel, Arvind Kaimal, Mubiru Frank, Tibakabikoba Harriet, Lwanga Isaac, Mohammed Lamorde, Castelnuovo Barbara
{"title":"乌干达一家城市HIV诊所实施常规病毒载量监测后对可检测病毒载量患者的管理评价","authors":"Nsumba Steven Mark,&nbsp;Musomba Rachel,&nbsp;Arvind Kaimal,&nbsp;Mubiru Frank,&nbsp;Tibakabikoba Harriet,&nbsp;Lwanga Isaac,&nbsp;Mohammed Lamorde,&nbsp;Castelnuovo Barbara","doi":"10.1155/2019/9271450","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To describe the clinical decisions taken for patients failing on treatment and possible implementation leakages within the monitoring cascade at a large urban HIV Centre in Kampala, Uganda.</p><p><strong>Methods: </strong>As per internal clinic guidelines, VL results >1,000 copies/ml are flagged by a quality assurance officer and sent to the requesting clinician. The clinician fills a \"decision form\" choosing: (1) refer for adherence counselling, (2) repeat VL after 3 months, and (3) switch to second line. We performed data extraction on a random sample of 100 patients with VL test >1,000 copies/ml between January and August 2015. For each patient, we described the action taken by the clinicians.</p><p><strong>Results: </strong>Of 6,438 patients with VL performed, 1,021 (16%) had >1,000 copies/ml. Of the 100 (10.1%) clinical files sampled, 61% were female, median age was 39 years (IQR: 32-47), 81% were on 1<sup>st</sup>-line ART, 19% on 2<sup>nd</sup>-line, median CD4 count was 249 cells/<i>µ</i>L (IQR: 145-390), median log<sub>10</sub> VL 4.42 (IQR: 3.98-4.92). Doctors' decisions were; refer for adherence counseling 49%, repeat VL for 25%, and switch to second line for 24% patients. Forty-one percent were not managed according to the guidelines. Of these, 29 (70.7%) were still active in care, 7 were tracked [5 (12.2%) lost to program, 2 (4.9%) dead] and 5 patients were not tracked.</p><p><strong>Conclusion: </strong>Despite the implementation of internal systems to manage patients failing ART, we found substantial leakages in the monitoring \"cascade\". Additional measures and stronger clinical supervision are needed to make every test count, and to ensure appropriate management of patients failing on ART.</p>","PeriodicalId":46303,"journal":{"name":"AIDS Research and Treatment","volume":"2019 ","pages":"9271450"},"PeriodicalIF":1.1000,"publicationDate":"2019-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/9271450","citationCount":"4","resultStr":"{\"title\":\"Evaluation of the Management of Patients with Detectable Viral Load after the Implementation of Routine Viral Load Monitoring in an Urban HIV Clinic in Uganda.\",\"authors\":\"Nsumba Steven Mark,&nbsp;Musomba Rachel,&nbsp;Arvind Kaimal,&nbsp;Mubiru Frank,&nbsp;Tibakabikoba Harriet,&nbsp;Lwanga Isaac,&nbsp;Mohammed Lamorde,&nbsp;Castelnuovo Barbara\",\"doi\":\"10.1155/2019/9271450\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To describe the clinical decisions taken for patients failing on treatment and possible implementation leakages within the monitoring cascade at a large urban HIV Centre in Kampala, Uganda.</p><p><strong>Methods: </strong>As per internal clinic guidelines, VL results >1,000 copies/ml are flagged by a quality assurance officer and sent to the requesting clinician. The clinician fills a \\\"decision form\\\" choosing: (1) refer for adherence counselling, (2) repeat VL after 3 months, and (3) switch to second line. We performed data extraction on a random sample of 100 patients with VL test >1,000 copies/ml between January and August 2015. For each patient, we described the action taken by the clinicians.</p><p><strong>Results: </strong>Of 6,438 patients with VL performed, 1,021 (16%) had >1,000 copies/ml. Of the 100 (10.1%) clinical files sampled, 61% were female, median age was 39 years (IQR: 32-47), 81% were on 1<sup>st</sup>-line ART, 19% on 2<sup>nd</sup>-line, median CD4 count was 249 cells/<i>µ</i>L (IQR: 145-390), median log<sub>10</sub> VL 4.42 (IQR: 3.98-4.92). Doctors' decisions were; refer for adherence counseling 49%, repeat VL for 25%, and switch to second line for 24% patients. Forty-one percent were not managed according to the guidelines. Of these, 29 (70.7%) were still active in care, 7 were tracked [5 (12.2%) lost to program, 2 (4.9%) dead] and 5 patients were not tracked.</p><p><strong>Conclusion: </strong>Despite the implementation of internal systems to manage patients failing ART, we found substantial leakages in the monitoring \\\"cascade\\\". Additional measures and stronger clinical supervision are needed to make every test count, and to ensure appropriate management of patients failing on ART.</p>\",\"PeriodicalId\":46303,\"journal\":{\"name\":\"AIDS Research and Treatment\",\"volume\":\"2019 \",\"pages\":\"9271450\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2019-12-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1155/2019/9271450\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AIDS Research and Treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1155/2019/9271450\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AIDS Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2019/9271450","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 4

摘要

目的:描述在乌干达坎帕拉的一个大型城市艾滋病中心的监测级联中,对治疗失败的患者所采取的临床决策和可能的实施泄漏。方法:根据内部临床指南,VL结果>1,000拷贝/ml由质量保证官员标记并发送给请求临床医生。临床医生填写一份“决定表”,选择:(1)转介依从性咨询,(2)3个月后重复VL,(3)切换到二线。我们在2015年1月至8月期间随机抽取了100例VL检测>1,000拷贝/ml的患者进行数据提取。对于每位患者,我们描述了临床医生所采取的行动。结果:6438例VL患者中,1021例(16%)的VL拷贝数大于1000拷贝/ml。在100份(10.1%)临床文件中,61%为女性,中位年龄为39岁(IQR: 32-47), 81%接受一线ART治疗,19%接受二线ART治疗,中位CD4计数为249个细胞/µL (IQR: 145-390),中位log10 VL 4.42 (IQR: 3.98-4.92)。医生的决定是;49%的患者接受依从性咨询,25%的患者重复VL, 24%的患者改用二线治疗。41%的人没有按照指导方针进行管理。其中,29例(70.7%)仍在积极接受治疗,7例被追踪[5例(12.2%)失去治疗计划,2例(4.9%)死亡],5例未被追踪。结论:尽管实施了内部系统来管理抗逆转录病毒治疗失败的患者,但我们发现监测“级联”存在重大漏洞。需要采取额外措施和加强临床监督,使每次检测都有意义,并确保对抗逆转录病毒治疗失败的患者进行适当管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Evaluation of the Management of Patients with Detectable Viral Load after the Implementation of Routine Viral Load Monitoring in an Urban HIV Clinic in Uganda.

Evaluation of the Management of Patients with Detectable Viral Load after the Implementation of Routine Viral Load Monitoring in an Urban HIV Clinic in Uganda.

Evaluation of the Management of Patients with Detectable Viral Load after the Implementation of Routine Viral Load Monitoring in an Urban HIV Clinic in Uganda.

Objective: To describe the clinical decisions taken for patients failing on treatment and possible implementation leakages within the monitoring cascade at a large urban HIV Centre in Kampala, Uganda.

Methods: As per internal clinic guidelines, VL results >1,000 copies/ml are flagged by a quality assurance officer and sent to the requesting clinician. The clinician fills a "decision form" choosing: (1) refer for adherence counselling, (2) repeat VL after 3 months, and (3) switch to second line. We performed data extraction on a random sample of 100 patients with VL test >1,000 copies/ml between January and August 2015. For each patient, we described the action taken by the clinicians.

Results: Of 6,438 patients with VL performed, 1,021 (16%) had >1,000 copies/ml. Of the 100 (10.1%) clinical files sampled, 61% were female, median age was 39 years (IQR: 32-47), 81% were on 1st-line ART, 19% on 2nd-line, median CD4 count was 249 cells/µL (IQR: 145-390), median log10 VL 4.42 (IQR: 3.98-4.92). Doctors' decisions were; refer for adherence counseling 49%, repeat VL for 25%, and switch to second line for 24% patients. Forty-one percent were not managed according to the guidelines. Of these, 29 (70.7%) were still active in care, 7 were tracked [5 (12.2%) lost to program, 2 (4.9%) dead] and 5 patients were not tracked.

Conclusion: Despite the implementation of internal systems to manage patients failing ART, we found substantial leakages in the monitoring "cascade". Additional measures and stronger clinical supervision are needed to make every test count, and to ensure appropriate management of patients failing on ART.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
AIDS Research and Treatment
AIDS Research and Treatment INFECTIOUS DISEASES-
CiteScore
3.10
自引率
0.00%
发文量
13
审稿时长
18 weeks
期刊介绍: AIDS Research and Treatment is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies focused on all aspects of HIV and AIDS, from the molecular basis of disease to translational and clinical research. In addition, articles relating to prevention, education, and behavior change will be considered
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信